Hao Yu

Hao Yu is the Chief Executive Officer (CEO) of Hangzhou KDx, a company specializing in biotechnology and healthcare. He has held this position since October 2017. His professional background includes significant experience in private equity and business development, particularly within the healthcare sector.13

Yu's educational credentials include studies at The Johns Hopkins University, which further solidified his expertise in the field.1 Prior to his role at Hangzhou KDx, he worked at CITIC Guoan Capital Management Co., where he gained valuable experience in investment and management.23

His LinkedIn profile highlights his focus on leveraging biotechnology for advancements in healthcare, emphasizing his commitment to innovation in this rapidly evolving industry.1